Published in Diabetes on March 01, 1994
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation (2012) 1.59
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24
Haemostatic markers are associated with measures of vascular disease in adults with hypertension. J Hum Hypertens (2009) 0.82
Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy. Wien Klin Wochenschr (2004) 0.80
Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes. Br J Pharmacol (1995) 0.80
Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients. Br J Ophthalmol (2000) 0.77
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest (1997) 3.66
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med (2001) 3.07
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67
Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia (2007) 2.01
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost (2003) 1.95
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68
Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension (1996) 1.64
Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans. Eur J Clin Invest (1999) 1.47
Neutron autoradiography imaging of selective boron uptake in human metastatic tumours. Appl Radiat Isot (2008) 1.44
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest (2001) 1.40
Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes. Diabete Metab (1994) 1.39
Dietary fat and gestational hyperglycaemia. Diabetologia (2001) 1.36
Percutaneous endoscopic gastrostomy: a long-term follow-up. Nutrition (1997) 1.29
An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest (1983) 1.20
The impact of diabetes on prescription drug costs: the population-based Turin study. Diabetologia (2008) 1.19
Should we consider gestational diabetes a vascular risk factor? Atherosclerosis (2006) 1.14
Obesity or diabetes: what is worse for the mother and for the baby? Diabetes Metab (2003) 1.13
Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med (2002) 1.09
Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest (1985) 1.05
In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis (1995) 1.05
Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Invest (2004) 1.01
Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus. Diabetologia (1999) 1.01
Dextrose infusion by artificial pancreas in diagnosis of insulinoma. Lancet (1982) 1.00
Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care (1996) 1.00
Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study. Diabetologia (2006) 1.00
National diabetes programs. Application of capture-recapture to count diabetes? Diabetes Care (1994) 1.00
Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia (2005) 0.99
Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia (2007) 0.99
Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Arch Intern Med (1989) 0.98
Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. Atherosclerosis (2011) 0.97
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem (2013) 0.96
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort. Int J Obes (Lond) (2011) 0.95
Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection. Clin Ther (2000) 0.95
Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids (2001) 0.95
Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure. Br J Pharmacol (2012) 0.95
Increasing trend of type I diabetes in children and young adults in the province of Turin (Italy). Analysis of age, period and birth cohort effects from 1984 to 1996. Diabetologia (2001) 0.94
Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy. Nutr Metab Cardiovasc Dis (2011) 0.94
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. Lupus (2012) 0.94
Low socioeconomic status as a risk factor for gestational diabetes. Diabetes Metab (2002) 0.94
Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics. Arch Intern Med (1987) 0.94
Influence of a familial history of diabetes on the clinical characteristics of patients with Type 2 diabetes mellitus. Diabet Med (2000) 0.94
Antibiotic GE37468 A: a novel inhibitor of bacterial protein synthesis. II. Structure elucidation. J Antibiot (Tokyo) (1995) 0.93
Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure. Br J Pharmacol (2012) 0.93
[A case of appendiceal mucocele associated with adenocarcinoma of the left colon]. G Chir (1999) 0.91
QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest (2004) 0.91
Relationship of residual beta-cell function, metabolic control and chronic complications in type 2 diabetes mellitus. Acta Diabetol (2000) 0.91
QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care (2000) 0.91
The incidence of type 1 diabetes is increasing in both children and young adults in Northern Italy: 1984-2004 temporal trends. Diabetologia (2009) 0.91
Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study. Diabet Med (2004) 0.90
Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 0.89
Low birthweight and metabolic abnormalities in twins with increased susceptibility to Type 2 diabetes mellitus. Diabet Med (2000) 0.89
Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients. Metabolism (2003) 0.89
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial. Nutr Metab Cardiovasc Dis (2001) 0.88
[Coagulation and fibrinolytic activity of blood from the corpus cavernosum]. Arch Ital Urol Nefrol Androl (1991) 0.88
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Leukemia (2006) 0.88
Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia. Metabolism (1995) 0.87
Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients. Diabetes Metab (2001) 0.87
Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.87
Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med (1996) 0.87
Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: immunological and genetic characterization. Diabetes (2001) 0.87
Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens. Diabet Med (2003) 0.86
A population-based prevalence survey of known diabetes mellitus in northern Italy based upon multiple independent sources of ascertainment. Diabetologia (1992) 0.86
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone. Eur J Clin Pharmacol (1992) 0.86
Insulin resistance in Graves' disease: a quantitative in-vivo evaluation. Eur J Clin Invest (1988) 0.86
Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction. J Endocrinol Invest (2008) 0.86
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis. Neth J Med (1999) 0.85
Percutaneous splenic artery occlusion for portal hypertension. A new mechanical technique for hypersplenism. Arch Surg (1983) 0.85
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. Clin Microbiol Infect (2011) 0.85
Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes. Diabet Med (1993) 0.84
Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort. Autoimmun Rev (2012) 0.84
Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels. Atherosclerosis (1993) 0.84
A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir. J Acquir Immune Defic Syndr (2001) 0.84
Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population. Diabetes (1987) 0.84
Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction. Metabolism (1999) 0.83
Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med (2001) 0.83
Redox-dependent toxicity of diepoxybutane and mitomycin C in sea urchin embryogenesis. Carcinogenesis (2000) 0.83
Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study. Diabetes Metab Res Rev (2001) 0.83
Insulin secretion and hepatic insulin clearance as determinants of hyperinsulinaemia in normotolerant grossly obese adolescents. Acta Paediatr (1998) 0.83
Short-term mortality risk in children and young adults with type 1 diabetes: the population-based Registry of the Province of Turin, Italy. Nutr Metab Cardiovasc Dis (2008) 0.83